Genworth Financial, Inc. accepted Darren W. Woodell’s resignation and appointed Jerome T. Upton, its Executive Vice President and Chief Financial Officer, interim Principal Accounting Officer effective November 6, 2026, until a new Principal Accounting Officer is appointed.
GNW · Genworth Financial Inc
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Short volume, last session
- 61%
- Last earnings
- Nov 5, 2026
- Latest filing
- 10-Q · Nov 5
- Price history
- Jan 2020 to Nov 2026
Up next
Latest documents
Genworth Financial reported a $(41) million third-quarter net loss versus $116 million, while adjusted operating income excluding Closed Block was $102 million versus $113 million. The board authorized an additional $500 million of share repurchases.
Genworth Financial reported a third-quarter net loss of $41 million and adjusted operating income, excluding the closed block, of $102 million. Its president and CEO will retire at the end of this year.
Genworth Financial reported a $41M net loss for the quarter ended September 30, 2026, while adjusted operating income excluding Closed Block was $102M; Enact returned $122M and $80M of shares were repurchased.
Genworth Financial, Inc. announced Thomas J. McInerney will retire as President and Chief Executive Officer effective December 31, 2026; Jerome T. Upton will succeed him and join the Board on January 1, 2027, while Angela R. Simmons becomes Executive Vice President and CFO.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q3 FY26 earnings call · Nov 5, 2026TL;DR. Genworth expects around $485 million of full-year 2026 capital returns from Enact, continued share repurchases, and growth in Enact insurance in force, while CareScout remained on track for its $25 million revenue target and expanded its distribution. Genworth posted a $41 million net loss, while the Closed Block, adverse assumption updates, CareScout's match pace and breakeven requirements, the AXA ruling and the universal-life reinsurance replacement created material headwinds.
- + Enact's primary insurance in force increased 1% year over year as new insurance written outpaced lapses and cancellations.
- + In-force rate actions have reduced closed-block long-term-care risk and delivered approximately $35 billion of net present value since 2012. new
- − Early analysis indicates that U.S. gap assumption updates could be materially unfavorable, particularly in LTC, due to cost-of-care, inflation and utilization trends. new
- − The October universal-life reinsurance replacement is expected to adversely affect fourth-quarter statutory earnings and the RBC ratio, although it will not affect GAAP results. new
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted expense ratio non-GAAP | 25% | 3Q 2026 | — |
| Adjusted operating income (loss), excluding Closed Block non-GAAP | $102M | Q3 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationAdjusted operating income (loss) -44M (non-GAAP)
+146M Adjustment to exclude Closed Block segment adjusted operating (income) loss
= Adjusted operating income (loss), excluding Closed Block 102M
|
|||
| Adjusted operating income (loss), excluding Closed Block per diluted share non-GAAP | $0.27 | Q3 2026 | — |
|
|
|||
| Available Assets Above PMIERs Requirements | $1.83B | 3Q 2026 | — |
|
|
|||
| Average price per share of share repurchases | $9.16 | year-to-date through September 30, 2026 | — |
| Average price per share of share repurchases since program inception | $6.66 | since the program's inception through September 30, 2026 | — |
| Book value per share | $23.33 | As of September 30, 2026 | — |
| Book value per share, excluding accumulated other comprehensive income (loss) | $26.79 | As of September 30, 2026 | — |
| CareScout matches | 1,532 | Q3 2026 | — |
|
|
|||
| CareScout Services revenues | $7M | three months ended September 30, 2026 | — |
| Common shares outstanding as of the balance sheet date | 370.4M | As of September 30, 2026 | — |
| Corporate and Other | -$30M | three months ended September 30, 2026 | — |
| Enact segment | $132M | three months ended September 30, 2026 | — |
| Enact segment adjusted operating income (loss) non-GAAP | $132M | 3Q 2026 | — |
|
|
|||
| GLIC consolidated RBC ratio | 274% | Q3 2026 | — |
|
|
|||
| Holding company cash and liquid assets | $320M | Q3 2026 | — |
| Loss ratio | 20% | Q3 2026 | — |
|
|
|||
| New Delinquencies | 14,401 | 3Q 2026 | — |
|
|
|||
| Operating ROE (quarterly average) non-GAAP | 8.5% | Quarter ended September 30, 2026 | — |
| Operating ROE (twelve month rolling average) non-GAAP | 9% | Twelve months ended September 30, 2026 | — |
| Paid Claims | 542 | 3Q 2026 | — |
|
|
|||
| PMIERs sufficiency ratio | 158% | Q3 2026 | — |
|
|
|||
| Primary Cures | 12,104 | 3Q 2026 | — |
|
|
|||
| Primary Delinquencies | 26,085 | 3Q 2026 | — |
|
|
|||
| Primary insurance in-force | 275.1B | Q3 2026 | — |
|
|
|||
| Primary new insurance written | $14.11B | Q3 2026 | — |
|
|
|||
| Reduction of holding company debt principal outstanding | $36M | year-to-date through September 30, 2026 | — |
| Share repurchases | $80M | Q3 2026 | — |
|
|
|||
| Share repurchases since program inception | $998M | since the program's inception through September 30, 2026 | — |
| Statutory earnings from in-force rate actions | $346M | 3Q 2026 | — |
| Total Reserves | $617M | 3Q 2026 | — |
|
|
|||
| U.S. GAAP basis expense ratio | 29% | 3Q 2026 | — |
| Adjusted operating income (loss), excluding Closed Block per share - Basic non-GAAP | $0.29 | Three months ended June 30, 2026 filing | — |
| Average invested assets and cash | $63.6B | Three months ended June 30, 2026 filing | — |
| Corporate and Other adjusted operating income (loss) non-GAAP | -$31M | Three months ended June 30, 2026 filing | — |
| Gross incremental premiums approved | $46M | Three months ended June 30, 2026 filing | — |
| Impacted in-force premiums | $189M | Three months ended June 30, 2026 filing | — |
| New insurance written | $15.2B | the second quarter of 2026 filing | — |
| Primary persistency rate | 80% | the second quarter of 2026 filing | — |
| Weighted-average percentage rate increase approved | 24% | Three months ended June 30, 2026 filing | — |
| Direct Primary Insurance In-Force | $273.95B | 2Q | — |
| Direct Primary Risk In-Force | $71.62B | 2Q | — |
| LTC MYRAP estimated net present value achieved since 2012 from IFAs | 34.8B | since 2012 through Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GNW
this stock
Genworth Financial Inc
|
$2.82B | -14.8% | +0.1% | 54.9 | 2.3% |
|
CILJF
China Life Insurance Co Ltd
|
$77.85B | -20.2% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$68.33B | +16.3% | — | — | 0.8% |
|
AFL
Aflac Inc
|
$61.71B | +13.1% | -9.3% | 18.4 | 1.8% |
|
MET
Metlife Inc
|
$61.34B | +23.6% | +8.6% | 12.7 | 1.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 9, 2026
- This year
- 19
Genworth Financial, Inc. accepted Darren W. Woodell’s resignation and appointed Jerome T. Upton, its Executive Vice President and Chief Financial Officer, interim Principal Accounting Officer effective November 6, 2026, until a new Principal Accounting Officer is appointed.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GNW | -8.6% | -14.0% | -9.5% | -12.4% | -14.8% |
| SPY | -5.5% | -6.3% | -5.6% | -5.3% | +5.0% |
| vs SPY | -3.1% | -7.7% | -3.9% | -7.1% | -19.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.